Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting

被引:30
作者
Gisbert, Javier P. [1 ]
Cooper, Alun [2 ]
Karagiannis, Dimitrios [3 ]
Hatlebakk, Jan [4 ]
Agreus, Lars [5 ]
Jablonowski, Helmut [6 ]
Zapardiel, Javier [7 ]
机构
[1] Hosp Univ Princesa, Dept Gastroenterol, Madrid, Spain
[2] Bridge Med Ctr, Crawley, W Sussex, England
[3] Athens Med Ctr, Dept Gastroenterol, Athens, Greece
[4] Haukeland Hosp, Inst Med, N-5021 Bergen, Norway
[5] Karolinska Inst, Ctr Family & Community Med, Huddinge, Sweden
[6] Klinikum Salzgitter GmbH, Salzgitter, Germany
[7] AstraZeneca, Madrid, Spain
关键词
QUALITY-OF-LIFE; GENERAL-POPULATION; SYMPTOMS; MANAGEMENT; GERD; QUESTIONNAIRE; CONSENSUS;
D O I
10.1186/1477-7525-7-60
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The impact of gastroesophageal reflux disease (GERD) on the daily lives of patients managed in primary care is not well known. We report the burden of GERD in a large population of patients managed in primary care, in terms of symptoms and impact on patients' daily lives. Methods: RANGE (Retrospective ANalysis of GERD) was an observational study that was conducted at 134 primary care sites across six European countries. All adult subjects who had consulted their primary care physician (PCP) during a 4-month identification period were screened retrospectively and those consulting at least once for GERD-related reasons were identified. From this population, a random sample of patients was selected to enter the study and attended a follow-up appointment, during which the Reflux Disease Questionnaire (RDQ), the GERD Impact Scale (GIS) and an extra-esophageal symptoms questionnaire were self-administered. Based on medical records, data were collected on demographics, history of GERD, its diagnostic work-up and therapy. Results: Over the 4-month identification period, 373,610 subjects consulted their PCP and 12,815 (3.4%) did so for GERD-related reasons. From 2678 patients interviewed (approximately 75% of whom reported taking medication for GERD symptoms), symptom recurrence following a period of remission was the most common reason for consultation (35%). At the follow-up visit, with regard to RDQ items (score range 0-5, where high score = worse status), mean Heartburn dimension scores ranged from 0.8 (Sweden) to 1.2 (UK) and mean Regurgitation dimension scores ranged from 1.0 (Norway) to 1.4 (Germany). Mean overall GIS scores (range 1-4, where low score = worse status) ranged from 3.3 (Germany) to 3.5 (Spain). With regard to extra-esophageal symptoms, sleep disturbance was common in all countries in terms of both frequency and intensity. Conclusion: In this large European observational study, GERD was associated with a substantial impact on the daily lives of affected individuals managed in the primary care setting.
引用
收藏
页数:8
相关论文
共 21 条
[1]   Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - Update 2004 [J].
Armstrong, D ;
Marshall, JK ;
Chiba, N ;
Enns, R ;
Fallone, CA ;
Fass, R ;
Hollingworth, R ;
Hunt, RH ;
Kahrilas, PJ ;
Mayrand, S ;
Moayyedi, P ;
Paterson, WG ;
Sadowski, D ;
van Zanten, SJV .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (01) :15-35
[2]   Health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease [J].
Chassany, O. ;
Holtmann, G. ;
Malagelada, J. ;
Gebauer, U. ;
Doerfler, H. ;
Devault, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) :1053-1070
[3]  
Dent J, 2008, SCAND J GASTROENTERO, V43, P34
[4]   Updated guidelines for the diagnosis and treatment of Gastroesophageal reflux disease [J].
DeVault, KR ;
Castell, DO .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :190-200
[5]   The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life [J].
Farup, C ;
Kleinman, L ;
Sloan, S ;
Ganoczy, D ;
Chee, E ;
Lee, C ;
Revicki, D .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) :45-52
[6]   Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians [J].
Flook, N. W. ;
Wiklund, I. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) :2071-2078
[7]   Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease [J].
Jones, R. ;
Liker, H. R. ;
Ducrotte, P. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (08) :1301-1307
[8]   The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care [J].
Jones, R. ;
Coyne, K. ;
Wiklund, I. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (12) :1451-1459
[9]   Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs?: A survey-based study [J].
Jones, Roger ;
Armstrong, David ;
Malfertheiner, Peter ;
Ducrotte, Philippe .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (04) :657-662
[10]   Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative [J].
Kulig, M ;
Leodolter, A ;
Vieth, M ;
Schulte, E ;
Jaspersen, D ;
Labenz, J ;
Lind, T ;
Meyer-Sabellek, W ;
Malfertheiner, P ;
Stolte, M ;
Willich, SN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (08) :767-776